CVAC logo

CureVac NV (CVAC)

Profile

Full Name

CureVac N.V.

Ticker Symbol

CVAC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

August 14, 2020

Indexes

Not included

Website

http://www.curevac.com

Employees

999

Key Details

Price

$3.19(+11.54%)

Market cap

$715.64M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$58.20M(-18.15% YoY)

Annual EPS

-$1.28(+8.23% YoY)

PE ratio

5.82

Next earnings date

May 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.19
CVAC price is $3.19

30-Day Relative Volume

1.10
CVAC 30-day relative volume is 1.10

Price Performance

Price Most recent change

+11.54%
CVAC price was up +11.54% on Apr 11, 2025

Price YTD change

-6.45%
CVAC price is down -6.45% since January 1st

Price 1-year change

+7.77%
CVAC price is up +7.77% year-on-year

Price 3-year change

-81.53%
CVAC price is down -81.53% over the past 3 years

Price Range

Price All-time high

$151.80
CVAC price is currently -97.90% below its historical high of $151.80

Price 3-year low

$2.21
CVAC price is currently +44.02% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$715.64M
CVAC market capitalization is $715.64 million

Market cap 3-year change

-77.85%
CVAC market capitalization is down -77.85% over the past 3 years

Market cap All-time high

$24.58B
CVAC market capitalization is currently -97.09% below its historical high of $24.58 billion

Market cap sector rank

73.62%
CVAC market capitalization is higher than 73.62% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.01%
CVAC shares outstanding is up +0.01% year-on-year

Shares Outstanding 3-Year Change

+19.89%
CVAC shares outstanding is up +19.89% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
CVAC beta is 1.10

200-day SMA

$3.20
CVAC price is currently -0.26% below its 200-day simple moving average

50-day SMA

$3.16
CVAC price is currently +1.01% above its 50-day simple moving average

RSI

57.01
CVAC 14-day relative strength index is 57.01

Volume

1.10
CVAC 30-day relative volume is 1.10

ATR

$0.22
CVAC average true range is $0.22

10-day Historical Volatility

106.20%
CVAC 10-day historical volatility is 106.20%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$58.20M
CVAC annual revenue is $58.20 million

Revenue Analysts estimate

$524.17M
CVAC annual revenue is currently -88.90% lower than the consensus analysts' forecast

Revenue 1-year change

-18.15%
CVAC annual revenue is down -18.15% year-on-year

Revenue Sector rank

49.38%
CVAC annual revenue is higher than 49.38% of companies in Healthcare sector

EPS

EPS

-$1.28
CVAC annual earnings per share is -$1.28

EPS Analysts estimate

$0.84
CVAC annual earnings per share is currently -252.52% lower than the consensus analysts' forecast

EPS 1-year change

+8.23%
CVAC annual earnings per share is up +8.23% year-on-year

EPS Sector rank

50.21%
CVAC annual earnings per share is higher than 50.21% of companies in Healthcare sector

Profit

Gross profit

-$76.44M
CVAC annual gross profit is -$76.44 million

Gross margin

-131.34%
CVAC annual gross profit margin is -131.34%

Operating profit

-$299.08M
CVAC annual operating income is -$299.08 million

Operating margin

-513.90%
CVAC annual operating profit margin is -513.90%

Net income

-$281.66M
CVAC annual net profit is -$281.66 million

Net margin

-483.96%
CVAC annual net profit margin is -483.96%

Expenses

Total expenses

$357.28M
CVAC annual total expenses is $357.28 million

Operating expenses

$222.64M
CVAC annual total operating expenses is $222.64 million

Cost of goods sold

$134.64M
CVAC annual cost of goods sold is $134.64 million

Selling, general & administrative expenses

$82.75M
CVAC annual SGA is $82.75 million

Depreciation and amortization

$25.32M
CVAC annual depreciation & amortization is $25.32 million

Interest expense

$2.70M
CVAC annual interest expense is $2.70 million

Income tax

$214.40K
CVAC annual income tax is $214.40 thousand

EBIT & EBITDA

EBIT

-$278.75M
CVAC annual earnings before interest & taxes is -$278.75 million

EBITDA

-$253.43M
CVAC annual EBITDA is -$253.43 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$871.33M
CVAC annual total assets is $871.33 million

Non current assets

$342.53M
CVAC annual long term assets is $342.53 million

Current assets

$528.80M
CVAC annual total current assets is $528.80 million

Cash and cash equivalents

$444.87M
CVAC annual cash & cash equivalents is $444.87 million

Accounts receivable

$15.84M
CVAC annual accounts receivable is $15.84 million

Inventory

$27.41M
CVAC annual inventory is $27.41 million

Liabilities

Total liabilities

$299.90M
CVAC annual total liabilities is $299.90 million

Long term liabilities

$93.87M
CVAC annual total long term liabilities is $93.87 million

Current liabilities

$206.03M
CVAC annual total current liabilities is $206.03 million

Accounts payable

$51.25M
CVAC annual accounts payable is $51.25 million

Debt

Total debt

$46.23M
CVAC annual total debt is $46.23 million

Total debt 1-year change

+2.44%
CVAC annual total debt is up +2.44% year-on-year

Long term debt

$40.70M
CVAC annual long term debt is $40.70 million

Short term debt

$5.53M
CVAC annual short term debt is $5.53 million

Equity & Capital

Shareholders equity

$571.43M
CVAC annual stockholders equity is $571.43 million

Book value

$571.43M
CVAC annual book value is $571.43 million

Retained earnings

-$1.73B
CVAC annual retained earnings is -$1.73 billion

Working capital

$322.77M
CVAC annual working capital is $322.77 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$290.02M
CVAC annual cash flow from operations is -$290.02 million

Cash from operations 1-year change

+3.9%
CVAC annual cash flow from operations is up +3.9% year-on-year

Cash from investing

-$59.76M
CVAC annual cash flow from investing activities is -$59.76 million

Cash from investing 1-year change

+39.39%
CVAC annual cash flow from investing activities is up +39.39% year-on-year

Cash from financing

$249.97M
CVAC annual cash flow from financing activities is $249.97 million

Cash from financing 1-year change

+275.2%
CVAC annual cash flow from financing activities is up +275.2% year-on-year

CAPEX

CAPEX

$59.76M
CVAC annual capital expenditures is $59.76 million

CAPEX 1-year change

-39.21%
CVAC annual capital expenditures is down -39.21% year-on-year

Free Cash Flow

Free cash flow

-$349.78M
CVAC annual free cash flow is -$349.78 million

Free cash flow 1-year change

+12.58%
CVAC annual free cash flow is up +12.58% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-131.34%
CVAC annual gross profit margin is -131.34%

Operating margin

-513.90%
CVAC annual operating profit margin is -513.90%

Net margin

-483.96%
CVAC annual net profit margin is -483.96%

ROA & ROE

ROA

-31.40%
CVAC annual return on assets is -31.40%

ROE

-49.27%
CVAC annual return on equity is -49.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

5.82
CVAC price to earnings ratio is 5.82

PE ratio Sector rank

7.84%
CVAC price to earnings ratio is higher than 7.84% of companies in Healthcare sector

PB Ratio

PB ratio

0.88
CVAC price to book ratio is 0.88

PB ratio Sector rank

42.11%
CVAC price to book ratio is higher than 42.11% of companies in Healthcare sector

PS Ratio

PS ratio

1.20
CVAC price to sales ratio is 1.20

PS ratio Sector rank

31.15%
CVAC price to sales ratio is higher than 31.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$145.20M
CVAC enterprise value is $145.20 million

Enterprise value Sector rank

54.58%
CVAC enterprise value is higher than 54.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.78
CVAC EV/EBITDA is 0.78

EV/EBITDA Sector rank

74.31%
CVAC EV/EBITDA is higher than 74.31% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.57
CVAC annual current ratio is 2.57

Quick ratio

2.43
CVAC annual quick ratio is 2.43

Leverage

Debt to equity

0.00
CVAC annual debt to equity ratio is 0.00

Interest coverage ratio

-103.28
CVAC annual interest coverage ratio is -103.28

Risk & Stability

Piotroski F-Score

7
CVAC piotroski f-score is 7

Altman Z-Score

-1.89
CVAC altman z-score is -1.89

Analyst ratings

Recent major analysts updates

Feb 14, 25 JMP Securities
Market Outperform
Sep 16, 24 JMP Securities
Market Outperform
Aug 16, 24 JMP Securities
Market Outperform
Jul 3, 24 JMP Securities
Market Outperform
Apr 25, 24 Leerink Partners
Market Perform
Apr 5, 24 Guggenheim
Neutral
Dec 31, 21 Deutsche Bank
Hold
Oct 22, 21 Deutsche Bank
Hold
Jun 17, 21 B of A Securities
Neutral
Apr 26, 21 Guggenheim
Buy

Institutional Ownership

Similar stocks

ABCL logo
AbCellera Biologics (ABCL)
EMBC logo
Embecta (EMBC)
HCSG logo
Healthcare Services (HCSG)
DAWN logo
Day One Biopharmaceuticals (DAWN)
PAHC logo
Phibro Animal Health (PAHC)
WEAV logo
Weave Communications (WEAV)
AXGN logo
AxoGen (AXGN)
GYRE logo
Gyre Therapeutics (GYRE)
AMN logo
AMN Healthcare Services (AMN)
  • What is the ticker symbol for CureVac NV?
  • Does CureVac NV pay dividends?
  • What sector is CureVac NV in?
  • What industry is CureVac NV in?
  • What country is CureVac NV based in?
  • When did CureVac NV go public?
  • Is CureVac NV in the S&P 500?
  • Is CureVac NV in the NASDAQ 100?
  • Is CureVac NV in the Dow Jones?
  • When was CureVac NV's last earnings report?
  • When does CureVac NV report earnings?

What is the ticker symbol for CureVac NV?

The ticker symbol for CureVac NV is NASDAQ:CVAC

Does CureVac NV pay dividends?

No, CureVac NV does not pay dividends

What sector is CureVac NV in?

CureVac NV is in the Healthcare sector

What industry is CureVac NV in?

CureVac NV is in the Biotechnology industry

What country is CureVac NV based in?

CureVac NV is headquartered in Germany

When did CureVac NV go public?

CureVac NV's initial public offering (IPO) was on August 14, 2020

Is CureVac NV in the S&P 500?

No, CureVac NV is not included in the S&P 500 index

Is CureVac NV in the NASDAQ 100?

No, CureVac NV is not included in the NASDAQ 100 index

Is CureVac NV in the Dow Jones?

No, CureVac NV is not included in the Dow Jones index

When was CureVac NV's last earnings report?

CureVac NV's most recent earnings report was on Apr 10, 2025

When does CureVac NV report earnings?

The next expected earnings date for CureVac NV is May 23, 2025
On this page